|
September 2006
Molecular imaging brings the vision of personalized medicine into focus
August 1, 2006 MI identifies variations in disease expression and therapeutic responsiveness for better clinical decision-making Scientific discovery adds spice to Britton Chance's long life
August 1, 2006 Dr. Britton Chance is one of the most inventive people in biomedical imaging. SUVs earn cheers for research but jeers for routine clinical use
August 1, 2006 In the quantitative world of molecular imaging, the standardized uptake value (SUV) looms large as a key measure of tumor aggressiveness and therapeutic response. MDs prove slow to adopt FDG-PET for cervical cancer staging
August 1, 2006 MI techniques recommend against unnecessary surgeries and monitor therapy Informatics sifts complex MI data
August 1, 2006 Computer tools guide research and streamline interpretation of clinical imaging results SPIO agents undergo scrutiny for cell tracking
August 1, 2006 Researchers weigh alternatives while they search for optimal ferric material Nuclear medicine embraces MI applications
August 1, 2006 Two top meetings showcase MI progress, while investment in basic sciences soars Combined approach evaluates breast cancer treatment progress
August 1, 2006 CONTEXT: Combining proton MR spectroscopic imaging, sodium MR, and PET/CT imaging may be an effective multimodality approach for detecting early response to chemotherapy in breast cancer patients, according to Dr. Michael Jacobs, a radiologist at Johns Hopkins School of Medicine. MRI tracks transplanted pancreatic cells labeled with iron-oxide contrast
August 1, 2006 The emerging therapy of islet transplantation has shown great promise for diabetes patients. Human trial of anti-F-18 FACBC tracer shows promise for prostate cancer
August 1, 2006 CONTEXT: While prostate-specific antigen testing and biopsy are the most conclusive ways for detecting prostate cancer, no clear-cut imaging technique exists for initial diagnosis and staging. Automated analysis of FDG-PET scans may predict rate of cognitive decline
August 1, 2006 FDG-PET imaging has become an accepted, reimburseable approach for diagnosing Alzheimer's and other neurodegenerative diseases. |
|
